NEW YORK (GenomeWeb News) — Luminex and Exiqon have struck an agreement under which Exiqon will non-exclusively distribute a line of microRNA products the companies designed for Luminex’s xMAP platform in 2006.
 
The FlexmiR product line is based on Luminex’s xMAP technology and Exiqon’s locked nucleic acid technology.
 
The deal also gives Exiqon non-exclusive rights to sell Luminex systems worldwide.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.